Live Breaking News & Updates on குமார் ராஜா

Stay updated with breaking news from குமார் ராஜா. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

ప్రభుత్వ జూనియర్, డిగ్రీ కాలేజీలో ఏర్పాటు చేయాలి : డివైఎఫ్ఐ నేత

ప్రభుత్వ జూనియర్, డిగ్రీ కాలేజీలో ఏర్పాటు చేయాలి : డివైఎఫ్ఐ నేత
prajasakti.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prajasakti.com Daily Mail and Mail on Sunday newspapers.

Andhra Pradesh , Kumar Raja , Saddam Hussein , Junior College , Kasturba High School , Kadapa District Vice President Tiny , High Schools , ஆந்திரா பிரதேஷ் , குமார் ராஜா , சதாம் ஹுசைன் , ஜூனியர் கல்லூரி , உயர் பள்ளிகள் ,

Oncternal Therapeutics, Inc. (ONCT) Q1 2021 Earnings Call Transcript


Operator
Good day ladies and gentlemen and welcome to Oncternal s Therapeutics Inc. first-quarter 2021 financial results call. [Operator instructions] At this time it is my pleasure to turn the floor over to your host Richard Vincent. Sir the floor is yours.
Rich Vincent
Chief Financial Officer
Thank you, Melinda. Good afternoon, everyone, and thank you for joining us today. Joining me on the call this afternoon are our president and CEO, Dr. James Breitmeyer; and our acting CMO, Dr.
Edwina Baskin-Bey. We welcome all of you. Today s call includes a business update and discussion of our 2021 first-quarter financial results which will be followed by Q&A. Today s press release and replay of today s earnings call will be available on the Investor Relations section of Oncternal s website for at least the next 30 days. ....

United States , San Diego , Kumar Raja , Carl Byrnes , James Breitmeyer , Hartaj Singh , Robert Burns , Edwina Baskin Bey , Jim Breitmeyer , Kumar Raja Brookline , Richard Vincent , Carl Byrnes Northland , Karolinska Institute , American Society For Clinical Oncology , Boehringer Ingelheim , Oppenheimer Co , American Association For Cancer Research , Lentigen Technology , Oncternal Therapeutics Inc , California Institute Of Regenerative Medicine , Uc San Diego School Of Medicine , Oncternal Therapeutics , Investor Relations , Safe Harbor , Private Securities Litigation Reform , Orphan Receptor ,